
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates
Shaimaa M. Badr-Eldin, Nabil A. Alhakamy, Usama A. Fahmy, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 26
Shaimaa M. Badr-Eldin, Nabil A. Alhakamy, Usama A. Fahmy, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 151-151
Open Access | Times Cited: 77
Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 151-151
Open Access | Times Cited: 77
An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
Pratibha Pandey, Fahad Khan, Minhaj Ahmad Khan, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3111-3111
Open Access | Times Cited: 39
Pratibha Pandey, Fahad Khan, Minhaj Ahmad Khan, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3111-3111
Open Access | Times Cited: 39
Regulating Cholesterol in Tumorigenesis: A Novel Paradigm for Tumor Nanotherapeutics
Huifeng Wu, Xiaodong Wu, Mengdan Zhao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1055-1076
Open Access | Times Cited: 10
Huifeng Wu, Xiaodong Wu, Mengdan Zhao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1055-1076
Open Access | Times Cited: 10
Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom
Ziyan Cui, Zegao Zhou, Ziyan Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117385-117385
Open Access | Times Cited: 9
Ziyan Cui, Zegao Zhou, Ziyan Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117385-117385
Open Access | Times Cited: 9
Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
Seong-Bin Yang, Nipa Banik, Bomin Han, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1378-1378
Open Access | Times Cited: 30
Seong-Bin Yang, Nipa Banik, Bomin Han, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1378-1378
Open Access | Times Cited: 30
SiO2–alginate–melittin nano-conjugates suppress the proliferation of ovarian cancer cells: a controlled release approach leveraging alginate lyase
Lihui Si, Shuli Yang, Ruixin Lin, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Lihui Si, Shuli Yang, Ruixin Lin, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Immunomodulatory activities and biomedical applications of melittin and its recent advances
Zohreh Jafari, Sahar Sadeghi, Mahsa Mirzarazi Dehaghi, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 7
Zohreh Jafari, Sahar Sadeghi, Mahsa Mirzarazi Dehaghi, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 7
Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy
Padakanti Sandeep Chary, Samia Shaikh, Naveen Rajana, et al.
Biomaterials Advances (2024) Vol. 162, pp. 213903-213903
Closed Access | Times Cited: 6
Padakanti Sandeep Chary, Samia Shaikh, Naveen Rajana, et al.
Biomaterials Advances (2024) Vol. 162, pp. 213903-213903
Closed Access | Times Cited: 6
Highly in vitro anti-cancer activity of melittin-loaded niosomes on non-small cell lung cancer cells
Pooyan Honari, Delavar Shahbazzadeh, Mahdi Behdani, et al.
Toxicon (2024) Vol. 241, pp. 107673-107673
Closed Access | Times Cited: 5
Pooyan Honari, Delavar Shahbazzadeh, Mahdi Behdani, et al.
Toxicon (2024) Vol. 241, pp. 107673-107673
Closed Access | Times Cited: 5
The Role of the BH4 Cofactor in Nitric Oxide Synthase Activity and Cancer Progression: Two Sides of the Same Coin
Diego Assis Gonçalves, Miriam Galvonas Jasiulionis, Fabiana Henriques Machado de Melo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9546-9546
Open Access | Times Cited: 27
Diego Assis Gonçalves, Miriam Galvonas Jasiulionis, Fabiana Henriques Machado de Melo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9546-9546
Open Access | Times Cited: 27
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Development and fabrication of a novel nano-bilosomal system for enhanced oral delivery of Trametinib: apoptotic induction and anticancer efficacy evaluation
Ananda Kumar Chettupalli, Suryanarayana Chokkarapu, Ankit Singh, et al.
Materials Technology (2025) Vol. 40, Iss. 1
Open Access
Ananda Kumar Chettupalli, Suryanarayana Chokkarapu, Ankit Singh, et al.
Materials Technology (2025) Vol. 40, Iss. 1
Open Access
Piceatannol-Loaded Bilosome-Stabilized Zein Protein Exhibits Enhanced Cytostatic and Apoptotic Activities in Lung Cancer Cells
Nabil A. Alhakamy, Giuseppe Caruso, Mohammed W. Al-Rabia, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 638-638
Open Access | Times Cited: 25
Nabil A. Alhakamy, Giuseppe Caruso, Mohammed W. Al-Rabia, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 638-638
Open Access | Times Cited: 25
Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells
Zuhier Awan, Shareefa A. AlGhamdi, Nabil A. Alhakamy, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1536-1548
Open Access | Times Cited: 17
Zuhier Awan, Shareefa A. AlGhamdi, Nabil A. Alhakamy, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1536-1548
Open Access | Times Cited: 17
RETRACTED: Ceftriaxone and Melittin Synergistically Promote Wound Healing in Diabetic Rats
Nabil A. Alhakamy, Giuseppe Caruso, Basma G. Eid, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1622-1622
Open Access | Times Cited: 23
Nabil A. Alhakamy, Giuseppe Caruso, Basma G. Eid, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1622-1622
Open Access | Times Cited: 23
Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 2
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 2
Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments
Ayşegül Varol, Serap Sezen, Dilhan Evcimen, et al.
Toxin Reviews (2022) Vol. 41, Iss. 4, pp. 1382-1395
Closed Access | Times Cited: 9
Ayşegül Varol, Serap Sezen, Dilhan Evcimen, et al.
Toxin Reviews (2022) Vol. 41, Iss. 4, pp. 1382-1395
Closed Access | Times Cited: 9
Cordycepin- melittin nanoconjugate intensifies wound healing efficacy in diabetic rats
Rasheed A. Shaik, Mohammed Alotaibi, Mohammed Z. Nasrullah, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 5, pp. 736-745
Open Access | Times Cited: 4
Rasheed A. Shaik, Mohammed Alotaibi, Mohammed Z. Nasrullah, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 5, pp. 736-745
Open Access | Times Cited: 4
Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer
Mohamed A. Alfaleh, Omar Fahmy, Mohammed W. Al-Rabia, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Mohamed A. Alfaleh, Omar Fahmy, Mohammed W. Al-Rabia, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
RETRACTED ARTICLE: Fluvastatin-Loaded Emulsomes Exhibit Improved Cytotoxic and Apoptosis in Prostate Cancer Cells
Nabil A. Alhakamy, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 9
Nabil A. Alhakamy, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 9
Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells
Nabil A. Alhakamy, Solomon Z. Okbazghi, Mohamed A. Alfaleh, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0264093-e0264093
Open Access | Times Cited: 6
Nabil A. Alhakamy, Solomon Z. Okbazghi, Mohamed A. Alfaleh, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0264093-e0264093
Open Access | Times Cited: 6
Overcoming chemoresistance in glioblastoma by fluvastatin via prenylation-dependent inhibition of Ras signaling
Long Cheng, Limei Yuan, Wei Wei, et al.
Human & Experimental Toxicology (2022) Vol. 41, pp. 096032712211259-096032712211259
Open Access | Times Cited: 6
Long Cheng, Limei Yuan, Wei Wei, et al.
Human & Experimental Toxicology (2022) Vol. 41, pp. 096032712211259-096032712211259
Open Access | Times Cited: 6
Colon Targeted Eudragit Coated Beads Loaded with Optimized Fluvastatin-Scorpion Venom Conjugate as a Potential Approach for Colon Cancer Therapy: In Vitro Anticancer Activity and In Vivo Colon Imaging
Osama A. A. Ahmed, Shaimaa M. Badr-Eldin, Giuseppe Caruso, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 12, pp. 3304-3317
Closed Access | Times Cited: 3
Osama A. A. Ahmed, Shaimaa M. Badr-Eldin, Giuseppe Caruso, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 12, pp. 3304-3317
Closed Access | Times Cited: 3
RETRACTED: Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation
Nabil A. Alhakamy, Usama A. Fahmy
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113619-113619
Closed Access | Times Cited: 3
Nabil A. Alhakamy, Usama A. Fahmy
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113619-113619
Closed Access | Times Cited: 3
Impact of Honeybee Venom Melittin on Cell Viability of Different Prostate Cancer Lineages
Ruslan Khalikov, Dar’ya D. Gromenko, Ш. Н. Галимов, et al.
Creative Surgery and Oncology (2022) Vol. 12, Iss. 2, pp. 118-122
Open Access | Times Cited: 1
Ruslan Khalikov, Dar’ya D. Gromenko, Ш. Н. Галимов, et al.
Creative Surgery and Oncology (2022) Vol. 12, Iss. 2, pp. 118-122
Open Access | Times Cited: 1